How Much Does SLU-PP-332 Cost in 2026? Pricing Breakdown

Key Takeaways

• SLU-PP-332 is not FDA-approved and is available for research purposes only, limiting cost data availability.
• Insurance typically does not cover SLU-PP-332 due to its research status.
• HSA/FSA funds are generally not applicable for SLU-PP-332 purchases.
• Telehealth services may offer bundled pricing, but availability is restricted due to legal status.
• Cost-saving options are limited; discount programs like GoodRx are generally not applicable.

What Is SLU-PP-332?

SLU-PP-332 is a small-molecule research compound identified as a selective agonist of peroxisome proliferator-activated receptor delta (PPARδ), primarily used in metabolic and mitochondrial research. For more details, visit the full profile.

Typical Cost Ranges

Due to its status as a research-only compound, SLU-PP-332 is not legally available for therapeutic use in the United States. As a result, specific cost data such as brand-name versus compounded versions, per-dose, or monthly pricing is not applicable. This limitation stems from its lack of FDA approval for clinical use.

Insurance Coverage

SLU-PP-332 is not covered by insurance plans, as it is not FDA-approved for any therapeutic indications. Insurers typically require FDA approval and clinical use authorization for coverage consideration. Consequently, patients interested in using SLU-PP-332 for research must typically pay out-of-pocket.

HSA/FSA Eligibility

Given its research-only designation, SLU-PP-332 does not qualify for Health Savings Account (HSA) or Flexible Spending Account (FSA) spending. These accounts generally require that the expenses be for FDA-approved medical treatments or therapies.

Telehealth vs. In-Person Pricing

Pricing structures for SLU-PP-332 through telehealth or in-person clinics are not applicable due to its research-only status. Telehealth services often bundle medication and consultation fees, but this is not relevant for SLU-PP-332 as it cannot be legally prescribed for therapeutic use.

Ways to Reduce Cost

Cost-saving measures such as manufacturer savings programs, compounding pharmacies, and patient assistance programs are not applicable to SLU-PP-332, given its non-therapeutic status. Discount tools like GoodRx also do not apply to research-only compounds.

Cost Compared to Alternatives

As SLU-PP-332 is not available for therapeutic use, direct cost comparisons to alternative treatments are not feasible. However, for other peptides used in metabolic research, such as BPC-157, costs may vary based on availability and regulatory status.

What to Ask Your Provider About Cost

• Is SLU-PP-332 available for therapeutic use, or is it restricted to research?
• Are there any clinical trials or research studies that I can participate in to access SLU-PP-332?
• What are the legal implications of using research-only peptides?

FAQ

Is SLU-PP-332 available for purchase?

SLU-PP-332 is available for research purposes only and is not legally available for therapeutic use or purchase for personal use.

Can I use insurance to cover the cost of SLU-PP-332?

No, insurance does not cover SLU-PP-332 as it is not FDA-approved for any therapeutic indications.

Are there any legal ways to obtain SLU-PP-332 for personal use?

Currently, SLU-PP-332 is only legally obtainable for research purposes under specific conditions and not for personal therapeutic use.

Can SLU-PP-332 be compounded?

Compounding pharmacies cannot legally compound SLU-PP-332 for therapeutic use due to its research-only status.

Are there any alternative peptides with similar effects?

While SLU-PP-332 is unique in its action as a PPARδ agonist, other peptides like AOD-9604 are used in metabolic research but differ in mechanism and regulatory status.

---

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.